Abstract. High-dose total body irradiation (TBI) has an established role as preparative regimen for bone-marrow transplantation in the treatment of chronic myelogenous leukemia (CML), but this regimen still has a relatively high rate of acute and late toxicity. Low-dose radiation (LDR) induces apoptosis of tumor cells and has numerous beneficial effects on normal tissues, including radiation homeostasis and adaptive response. Based on the previous evidence, in the present study, K562 cells were exposed to LDR, high-dose radiation (HDR), and LDR in combination with HDR to investigate the possible mechanism of the apoptotic effect and hypersensitivity induced by LDR. The apoptotic rate increased in all radiation groups in a time-dependent manner. An upregulation of Bax protein expression and a downregulation of Bcl-xl in a dose-dependent manner in human leukemia K562 cells was observed. However, the expression of p53 protein did not change in all of the radiation cell groups. The mitochondrial membrane potential (ΔΨm) in K562 cells decreased in all of the radiation cell groups in a dose-dependent manner. Furthermore, the decrease of ΔΨm was enhanced in the LDR/HDR group compared with that in the LDR or HDR groups. The activity of caspase-3 was enhanced in all of the radiation groups. In the LDR/HDR group, the activity of caspase-3 was higher than that in the HDR or LDR groups. The present study provided preliminary experimental evidence of LDR being beneficial in combination with TBI in the treatment of CML.
Introduction
Radiation therapy has wide clinical utility, particularly in the treatment of solid tumors (1) . The application of radiation therapy in hematological malignancies initially began in the 1920s, using the technique of low-dose total body irradiation (LDBI) for the treatment of low-grade malignant non-Hodgkin's lymphoma and chronic lymphocytic leukemia, which achieved notable efficacy (2) (3) (4) .
Until the middle of the 20th century, high-dose total body irradiation (TBI) replaced LDBI in the pretreatment of bone marrow transplantation, establishing a classic conditioning regimen of TBI/CY that remains in use today. TBI has an established role as a preparative regimen for bone-marrow transplantation in the treatment of hematological malignancies. Numerous randomized trials have demonstrated that the clinical outcomes obtained from the combination of TBI and cyclophosphamide are equivalent to those based on chemotherapeutic agents, and are occasionally better than them. Despite the therapeutic progress and the improvement in the overall survival in recent years, this preparative regimen still has a relatively high rate of acute and late toxicity, including gastrointestinal toxicity, infections, hemorrhagic cystitis, hepatic veno-occlusive disease (VOD), acute graft-versus-host disease (aGVHD) and interstitial pneumonia (IP). Given the limitations of radiation therapy, novel treatment strategies that overcome acquired toxicity are urgently required.
Luckey (5) first proposed the excitatory effect produced by low-dose irradiation (LDR). The study's experimental results demonstrated that moderate LDR is not only harmless to humans, but also beneficial to life activity by promoting fertility and reproduction, increasing physical defense capability, producing self-adaptability and enhancing damage repair ability. It is, however, the apparent anti-tumor, radiation hypersensitivity and self-adaptive effects, which were generated by LDR, that raised marked concern amongst oncologists.
LDR is a type of irradiation with a radiation dose of <20c Gy (low LET) and <5c Gy (high LET), with a dose rate that ranges between 5-10c Gy/min. LDR confers significant benefits by inducing a radio-adaptive response, where pre-irradiation with low doses allows the body to produce an adaptive response to subsequent high-dose irradiation, thereby reducing the radiation damage effect caused by high doses radiation. Olivieri et al (6) first proposed that a low-level radiation may induce genetic self-adaptive responses in human lymphocytes, including cytogenetic, gene mutation, cell survival as well as immune adaptive responses.
The possible mechanisms responsible for the difference in the induction of radio-adaptive response by LDR between normal tissues and tumor cells have remained controversial. Hendrikse et al (7) demonstrated that p53 has an important role in determining the LDR-induced adaptive response. However, evidence exists that does not support the significance of p53 in the induction of radioresistance by LDR. Seong et al (8) demonstrated that radio adaption or radio sensitivity induced by LDR was independent of the expression of p53 in the tumor cells, which may be associated with members of the B-cell lymphoma 2 (Bcl-2) family.
In view of the biological characteristics of LDR and the limitation caused by radiation toxicity of TBI clinically, it is highly important that the adaptive response induced by the LDR may be able to alleviate the subsequent high dose of TBI treatment toxicity if combining LDR with TBI. However, whether LDR is able to induce radioadapative responses remains dependent on several factors, including cell types (9) .
K562 is the human erythroleukemia cell line of CML in the blastic phase (10) . Bcl-2 extra large (Bcl-xl), the inhibitory apoptosis protein of the Bcl-2 family, has a similar function to Bcl-2 in inhibiting apoptosis of tumor cells by a variety of mechanisms, including inhibiting the decrease of the mitochondrial membrane potential (ΔΨm). Bcl-2-associated X (Bax), the apoptosis-promoting protein, mainly promotes the decrease of ΔΨm through the formation of retinoid X receptor (RXR)-RXR, resulting in the subsequent induction apoptosis. p53, the apoptosis activating gene, is involved in apoptosis regulation through multiple pathways. K562 is the 135th codon insertion mutation of p53 RNA, which leads to a complete loss of function of p53. K562 has a marked resistance to chemotherapy and radiotherapy (11) .
The present study aimed to detect the anti-tumor effect of LDR and LDR/HDR to K562 cells in vitro and to examine their possible mechanisms with the purpose of providing experimental evidence for the feasibility of the conditioning regimen, TBI combined with LDR, as a pre-transplant conditioning regimen in the treatment of leukemia.
Materials and methods
Cell lines and culture conditions. The human cell line K562 was a gift from Jiangsu Institute of Hematology, Suzhou University First Hospital (Jiangsu, China). The cells were cultured in RPMI-1640 (Gibco-BRL, Carlsbad, CA, USA) supplemented with 10% heat inactivated fetal bovine serum (FBS; Gibco-BRL), 4 mM glutamine (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), 50 U/ml penicillin and 50 µg/ml streptomycin (Gibco-BRL) at 37˚C in a humidified atmosphere with 5% CO 2 . The cells were screened routinely to verify the lack of mycoplasma contamination and used in the long phase of growth.
Experimental classification. The K562 cells in the long phase of growth were divided into four groups (ten subgroups), including a blank control group (0 Gy; BC group), a low-dose radiation group (LDR group), a high-dose radiation group (6 Gy, HDR group) and a low-dose radiation combined with high-dose radiation group (LDR/HDR group). The LDR groups were re-divided into four subsets according to the irradiation dose: 0.08 Gy, 0.2 Gy, 0.5 Gy and 0.8 Gy. LDR/HDR groups were divided into four subsets: 0.08 Gy/6 Gy, 0.2 Gy/6 Gy, 0.5 Gy/6 Gy and 0.8 Gy/6 Gy. Each dosage group was assayed in triplicate.
Irradiation conditions. The K562 cells were cultivated in flasks, covered with a 1.5 cm lucite plate and irradiated at the different doses with 6 MV X-rays (Clinac 23EX, Varian, Palo Alto, CA, USA) using a 20 cm x 20 cm irradiation field and 100 cm of source skin distance, with dose rates of 0.05 Gy/min for LDR and 2 Gy/min for HDR. LDR was administered 12 h prior to HDR. The cell cultures were maintained in cultivation and harvested at the time-points of 24, 48, 72, 96 and 120 h following irradiation at 37˚C in 5% CO 2 with saturated humidity.
Measurement of apoptosis.
Apoptosis was examined using a fluorescein isothiocyanate (FITC)-labeled Annexin V/propidium iodide (PI) apoptosis detection kit (BD Pharmingen, San Diego, CA, USA) according to the manufacturer's instructions. Briefly, 1x10 6 K562 cells were harvested and washed twice with cold phosphate-buffered saline (PBS). The cells were then resuspended in 250 µl 1x binding buffer. Next, 5 µl Annexin V-FITC and 5 µl PI were added. Flow cytometric analysis was performed immediately following staining. The data acquisition and analysis were performed on a fluorescence-activated cell scanner (FACScan) flow cytometer (Becton Dickinson, San Jose, CA, USA). Cells in the early stages of apoptosis were Annexin V-positive and PI-negative, whereas the cells in the late stages of apoptosis were both Annexin V and PI-positive.
Western blot analysis.
To determine the pre-and post radiation expression of Bcl-xl, Bax and p53 proteins, western blot analysis was performed. The cells were harvested from the plates, and aliquots of cell extracts were separated by 12% SDS-PAGE. The proteins were then transferred to a nitrocellulose membrane and incubated overnight at 4˚C with the following rabbit polyclonal antibodies: Anti-p53, anti-Bcl-xl, anti-Bax (Cell Signaling Technology, Inc., Beverly, MA, USA) and anti-β-actin antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), respectively. The membranes were then washed and incubated with alkaline phosphatase conjugated secondary antibodies in TBST (Tris-buffered saline with Tween-20) for 2 h and developed using a nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate color substrate (Promega Corporation, Madison, WI, USA). The density of the protein bands on the membrane were scanned and analyzed with an image analyzer (Labworks software; UVP, Inc., Upland, CA, USA). Assay of caspase-3 activity. Caspase-3 activity was assessed using the caspase-3 colorimetric assay kit (Sigma-Aldrich, St. Louis, MO, USA), following the manufacturer's instructions. This assay is based on the detection of the amount of N-acetyl-Asp-Glu-Val-Asp-p-nitroanilide (Ac-DEVD-p-NA) substrate cleaved by cell lysates to release the colored p-NA molecule. In the present study, PANC-1 cells were exposed to punctata extract (100 µg/ml; Sigma-Aldrich) or staurosporine (0.1 µg/ml). Following radiation, the cells were washed in PBS and suspended in lysis buffer [50 mM hydroxyethyl piperazineethanesulfonic acid (HEPES) pH 7.4, 5 mM cholamidopropyl dimethylammonio-1-propanesulfonate (CHAPS) and 5 mM dithiothreitol (DTT)] for 15 min at a concentration of 10 7 cells per 100 µl buffer. The lysed cells were centrifuged at 16,000 x g, 4˚C for 15 min. The protein concentrations in lysates were determined using the Bradford assay. Equal amounts of protein (20 µg) from each sample were added to wells containing the assay buffer (20 mM HEPES, pH 7.4, 0.1% CHAPS, 5 mM DTT, 2 mM EDTA), followed by 10 µl of Ac-DEVD-p-NA (20 mM), bringing the total volume of each well to 100 µl. The caspase-3 activity was assessed by measuring the optical density (OD) at 405 nm using an enzyme mark instrument (Multiskan MK3; Thermo Labsystems, Waltham, MA, USA). All of the experiments were performed in duplicate and repeated at least three times.
Assay of
Statistical analysis. Data are expressed as the mean ± standard deviation. The significance of the differences between groups was determined using one-way analysis of variance and the Student-Newman-Keuls q-test for intergroup comparison using SPSS statistical software version 13 (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

Effect of LDR on apoptosis in K562 cells.
Compared with the control group, the number of apoptotic K562 cells in all of the LDR groups increased marginally at 24 and 120 h following radiation; however, the difference was not statistically significant (P>0.05). Notably, the apoptotic rate of K562 cells in all of the LDR groups increased markedly at 48, 72 and 96 h, with statistically significant differences when compared with the control group. The apoptotic rate of K562 cells increased in the LDR group with statistical significance compared with the control group (P<0.01). In the 0.5 Gy group, the apoptotic rate of K562 cells increased to 4.24±0.22% at 72 h, 6.28±0.30% Fig. 1 ).
Effect of LDR/HDR on apoptosis in K562 cells.
The apoptotic rate of K562 cells markedly increased at 24 h following radiation in the HDR group, peaking at 120 h (17.38±0.92%~29.27±0.93%), with statistically significant differences when compared with the control group (P<0.01). The apoptotic rate of K562 cells in the two LDR/HDR groups (0.08 Gy+6 Gy, 0.2 Gy+6 Gy) demonstrated no statistically significant differences when compared with the HDR group at identical time points (P>0.05). Notably, the apoptotic rate of the K562 cells in the LDR/HDR groups (0.5 Gy+6 Gy, 0.8 Gy+6 Gy) enhanced significantly with the dose increase of LDR in the other two LDR/HDR groups at 72 h, peaking at 120 h (27.91±1.07%~29.27±0.93%) following radiation in comparison with the HDR groups at the same time points (P<0.01; Fig. 1 ).
Bcl-xl protein expression is downregulated by LDR alone or in combination with HDR (LDR/HDR).
The expression of Bcl-xl protein in K562 cells changed in a dose-dependent manner at 24 h following radiation. Western blot analysis showed that the expression levels of Bcl-xl protein were 2.65±0.30 (0.5 Gy) and 2.07±0.31 (0.8 Gy) at 24 h following radiation, which were evidently lower than those in the 0.2 Gy radiation (3.44±0.18) and the blank control (3.96±0.08; P<0.05) groups. The Bcl-xl protein expression was reduced even further in the combined LDR/HDR group (6 Gy) as compared with that in the LDR group in K562 cells ( Fig. 2 ; Table I ).
Bax protein expression is upregulated by LDR alone or in combination with HDR.
The Bax protein expression in K562 cells changed in a dose-dependent manner. Using western blot analysis, the expression of Bax in all of the LDR groups exhibited a significant difference compared with the control group (0 Gy) at 24 h following radiation. However, in the combined LDR/HDR group (6 Gy), the Bax protein expression levels were notably higher in the K562 cells than those in either the LDR or HDR groups at 24 h following radiation (P<0.01; Fig. 2 ). (Fig. 3) . A B Measurement of caspase-3 activities. Caspase-3 activation is a crucial component in the apoptotic signaling cascade. To further elucidate the mechanism of cell apoptosis induced by irradiation, a caspase-3 colorimetric assay was conducted to assess the levels of caspase-3 activation in cells at 24 h following LDR or LDR/HDR treatments. LDR mildly increased caspase-3 activity with a statistically significant difference among the LDR groups (P<0.05). Furthermore, when the K562 cell cultures were co-treated with LDR and HDR, the activity of caspase-3 was increased significantly compared with that in the cells treated with HDR alone (P<0.05; Figs. 4 
Wild-type p53 protein expression is unaltered by LDR or LDR/HDR treatment.
and 5).
Discussion
LDR is able to induce a number of biological effects on the tissues of the body or cell cultures, including radiation homeostasis, adaptive response, hyper-sensitivity and bystander effect (12) . Experimental studies suggested that the efficacy of LDBI is mainly attributed to the mechanisms of immune enhancement (13) (14) (15) (16) (17) (18) , induction of apoptosis (19, 20) , intrinsic hypersensitivity (21) and contribution of antioxidant enzymes to low-radiation doses (22) . These effects are not mutually exclusive, and it is quite plausible that more than one mechanism is functional at the same time, or that they all work simultaneously.
Numerous human tumor cell lines exhibit a low-dose hyper-sensitivity to radiation, known as hyperradiosensitivity (HRS). This is most commonly manifested <0.5 Gy as a clear deviation from the standard linear-quadratic cell survival response extrapolated from higher doses back to 0 Gy. It is accompanied by an increase in radioresistance between 0.5 and 1 Gy, known as increased radioresistance. Hypersensitivity to radiation is one of the leading mechanisms involved in the induction of tumor cell apoptosis. Enns et al (23) examined the response of human A549 lung carcinoma and T98G glioma cells to γ-radiation from doses of 0-2 Gy delivered at 0.18 and 0.22 Gy/min, and observed that there was a marked hypersensitivity at radiation doses <0.5 Gy. In this study it was also suggested that low-dose hypersensitivity is associated with p53-dependent apoptosis. A possible explanation is that at very low-acute doses, cells do not to upregulate radioprotective repair mechanisms to repair damage and instead, apoptosis is initiated (24) . Furthermore, other evidence supported the existence of a correlation between the enhanced low-dose cell death and apoptosis. It was demonstrated that low-dose HRS is likely to be a measure of the apoptosis of radiation-damaged G2-phase-specific cells that evade early G2-phase checkpoint arrest (25) . A three-component model of hypersensitivity was proposed that consisted of damage recognition, signal transduction and DNA damage repair. The foundation of the model is a rapidly occurring dose-dependent pre-mitotic cell cycle checkpoint that is specific to cells exposed to irradiation whilst in G2 phase (26) . Olive and Durand (27) studied the apoptotic mechanisms of hematopoietic cell lines, finding that they generally undergo rapid apoptosis (within hours) following radiation, in contrast to cells of non-hematopoietic origin, which are more likely to be characterized by delayed apoptosis (within days). Tolerance for DNA damage appears to be reduced in cells capable of rapid apoptosis, and those hematopoietic cells are sensitized to ionizing radiation when their apoptotic response mechanisms are fully functional. This rapid apoptotic response demonstrates minor sensitivity to the cell cycle phase or radiation dose rate. Various therapeutic strategies have been used for the treatment of CML. These include cytotoxic agents, including hydroxyurea, interferon-α (IFN-α)-based regimens, tyrosine kinase inhibitors (TKI) and allogeneic hematopoietic stem cell transplantation (allo-HSCT). The cumulative evidence generated thus far demonstrated that CML remains a difficult malignancy to treat, with the median survival ranging between 3-4 years. Despite the introduction of targeted therapies, such as TKI drugs, the prognosis of CML has not changed to a large extent. As a result, novel effective treatments are urgently required.
Takahashi et al (28) previously found that small doses of X-rays accelerated the process of cell death, using a dye exclusion test in MOLT-4 cells of human T-cell leukemic origin, in which radiation-induced cell death has been well characterized to proceed via apoptosis. Chen and Sakai (29) also reported that by administering 0.2 Gy of X-rays 12 h prior to a challenge with 5 Gy irradiation, the process of apoptosis in human leukemic MOLT-4 cells was accelerated. The acceleration was associated with an increase in caspase-3 activity, a disruption of the mitochondrial transmembrane potential and an accumulation of p53 proteins. This finding is in contrast to the radiation-adaptive responses in which a small dose of pre-irradiation would induce certain radiation resistance and decrease the cell death following radiation with higher doses. The studies described above performed in vitro have demonstrated that LDR may induce apoptosis in leukemia cells containing the wild-type p53 gene. This radiation-induced apoptosis requires further study.
The present study demonstrated that the increase in the apoptotic rate of K562 cells following LDR exhibits a well defined dose-dependent response. The proportion apoptotic K562 cells, particularly when exposed to 0.5 or 0.8 Gy, was higher than in the other exposure groups. This possibly results from the high expression of Bcl-xl protein in K562 cells, which, to a certain extent, contributes to radioresistance, whereas the p53 mutation in K562 cells leads to no evident retardation in the G1 phase. Apoptosis of K562 cells under LDR increased following 48 h and lasted until 96-120 h post-irradiation, characterized by delayed apoptosis and longer apoptosis duration. Furthermore, this type of apoptosis in K562 cells had no correlation with the p53 mutation status, suggesting the possible involvement of a p53-independent apoptotic pathway, which belongs to a slow-response cell population, only progressing through mitosis before apoptosis would have occurred. Waldman et al (30) reported that in the absence of p21 or p53 in certain tumor cells DNA damage caused cell cycle arrest in the G2-like stage, but cells additionally proceeded through S phase without undergoing mitosis. As a result, the cells acquired grossly deformed, polyploid nuclei and subsequently died through apoptosis. This apoptosis, triggered by DNA-damaging agents that are able to trigger S/M uncoupling, is a mechanism of the non-p53-dependent-apoptotic pathway. In the present study, it was identified that HDR combined with LDR enhanced the lethal effect to K562 cells, leading to an increased apoptotic rate and extending cell apoptosis by the same apoptosis pathway as Waldman et al previously reported. The Bcl-2 gene family has a crucial regulatory role in cell apoptosis. High expression of Bcl-2 family proteins in tumor cells is an important factor in the resistance to chemoradiation and consequently, there is a high correlation with clinical prognosis in treatment. The Bcl-xl gene is also an apoptosis-inhibiting gene in the Bcl-2 gene family. Jiang et al (31) previously observed that pre-exposure to 0.075 Gy of X-ray prior to 4 Gy of X-rays induced a higher apoptotic effect and an increased expression of apoptosis-associated genes, p53 and Bax, along with a lower expression of anti-apoptosis gene Bcl-2, in tumor cells (lung carcinoma cell line NCI-H446, glioma cell line U251, erythroleukemia cell line K562 and acute promyelocytic leukemia cell line HL60) than those in the tumor cells exposed to 4 Gy of X-rays alone. In the present study, LDR significantly decreased the expression of the Bcl-xl protein and increased the expression of Bax in a dose-dependent manner, and lowering the Bcl-xl/Bax ratio promoted the apoptosis of K562 cells. When the Bcl-xl protein expression was high, the K562 cells exhibited resistance to common chemoradiation. However, when exposed to LDR, the expression of Bcl-xl protein was downregulated, resulting in DNA damage and the induction of cell apoptosis. Of note, LDR/HDR further promoted the reduction of Bcl-xl protein and the production of Bax protein in K562 cells, leading to a higher apoptotic rate compared with HDR alone.
The activation of the mitochondria-mediated apoptotic pathway is essential for programmed cell death. Mitochondrial membrane permeability and the alteration of membrane potentials are essential aspects in the apoptotic process, resulting in release of CytoC and initiation of apoptosis by activating the caspase reaction cascade. Yu et al (32) also discovered that LDR exposure (0.0075 Gy) increased the therapeutic efficacy of cyclophosphamide (CTX) to S180 sarcoma cells. The apoptosis of tumor cells increased significantly following LDR. The cell cycle was more significantly arrested upon exposure to LDR followed by CTX as compared with that resulting from exposure to CTX chemotherapy only. This was due to LDR+CTX inducing greater cytochrome c levels and caspase-3 activity than CTX chemotherapy only in tumor cells. The present study demonstrated that LDR significantly decreased the ΔΨm and increased caspase-3 activity. Furthermore, in combination with HDR, the ΔΨm in K562 cells was severely diminished and higher caspase-3 activity was present, indicating that LDR was able to enhance the radiation efficacy of HDR. Notably, no evident change in the level of p53 protein expression occurred following combined LDR/HDR. It was therefore assumed that this result was likely owing to a mutation of p53 in K562 cells.
In conclusion, LDR was able to induce apoptosis of K562 cells and enhanced the lethal effect of HDR on K562 cells combined with HDR. It provided evidence for the feasibility of the conditioning regimen of TBI combined with LDR, as a pre-transplant conditioning regimen in the treatment of leukemia. However, to achieve this synergistic effect, a dosage of LDR between 0.5 Gy and 0.8 Gy is required. The possible mechanism of action is through the p53-independent apoptosis pathway. K562 cells would undergo DNA damage with LDR, which initiates the mitochondria-mediated apoptotic pathway, including upregulation of Bax protein expression and downregulation of Bcl-xl protein expression, resulting in the breakdown of ΔΨm. The outer membrane of mitochondria becomes permeable to cytochrome c, and when cytochrome c is released to the cytosol, it triggers caspase cascade reactions. It is suggested that LDR in combination with HDR, when administered at the appropriate dosage, is able to increase the apoptotic index of HDR by accelerating apoptosis as well as increasing apoptosis duration and incidence.
